Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q4 earnings results on Tuesday, March 8, 2022 at 08:05 AM.
Here's what investors need to know about the announcement.
Earnings
Corbus Pharmaceuticals beat estimated earnings by 27.27%, reporting an EPS of $-0.08 versus an estimate of $-0.11.
Revenue was down $658.20 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 0.95% increase in the share price the next day.
Here's a look at Corbus Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.12 | -0.15 | -0.25 |
| EPS Actual | -0.02 | -0.15 | -0.14 | -0.10 |
| Revenue Estimate | 650.00K | 870.00K | 960.00K | 1.49M |
| Revenue Actual | 97.32K | 136.56K | 647.82K | 658.20K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
